EU approval for Revolade for paediatric patients with chronic ITP
7 April 2016 | By Victoria White
The approval includes the use of a new oral suspension formulation of Revolade designed for younger children who may not be able to swallow tablets...
List view / Grid view
News
Release of future proofed Artwork Lifecycle Management System by Perigord leads way for Life Science companies
7 April 2016 | By Perigord
Perigord has officially launched the latest release of their proprietary innovative software, GLAMS (Global Artwork Management System)...
EC expands use of Opdivo in NSCLC and approves its use in advanced RCC
6 April 2016 | By Victoria White
The EC has approved Opdivo (nivolumab) for locally advanced or metastatic NSCLC after prior chemotherapy and in advanced RCC after prior therapy...
Black Swan Analysis has added to its Epiomic Epidemiology series of reports with Benign Prostatic Hypertrophy Forecast in 17 Major Markets 2016-2026
6 April 2016 | By Black Swan Analysis
Research and Markets has announced the addition of the "Benign Prostatic Hypertrophy Forecast in 17 Major Markets 2016-2026" report to their offering...
Coulter Partners has placed Dr Neil Brewis as Chief Scientific Officer and Michael Davies as VP Protein Science at F-star
Coulter Partners has placed Dr Neil Brewis as Chief Scientific Officer and Michael Davies as VP Protein Science at F-star, a leading biopharmaceutical company developing novel bispecific antibodies with a focus on immuno-oncology.
Allergan and Pfizer terminate merger agreement
6 April 2016 | By Victoria White
The decision was driven by the actions announced by the US Department of Treasury, which the companies concluded qualified as an “Adverse Tax Law Change”...
Pioneering treatment could freeze out phantom limb pain
6 April 2016 | By Victoria White
Cryoablation therapy, a targeted treatment using cold blasts, shows promise in improving the quality of life for patients suffering phantom limb pain...
Positive study results for Oasmia’s XR17 nanotechnology
6 April 2016 | By Victoria White
The confirmation of XR17 as a drug delivery system creates the potential for licensing opportunities in additional therapeutics outside of oncology...
FDA approves Inflectra (biosimilar infliximab) in the US
6 April 2016 | By Victoria White, Digital Content Producer
With this approval, Celltrion's Inflectra becomes the first biosimilar monoclonal antibody (mAb) medication to receive approval in the US...
CHMP issues positive opinion of AstraZeneca’s pandemic influenza vaccine
5 April 2016 | By Victoria White
This recommendation allows a vaccine containing a strain of pandemic potential to be developed and authorised in advance of a pandemic being declared...
CHMP adopts positive opinion of Trevicta for maintenance treatment of schizophrenia
5 April 2016 | By Victoria White
If approved, this 3‑monthly injection will allow patients to maintain an optimal level of treatment in their blood with fewer administrations...
Encouraging top-line interim results for RHB-104 in RRMS
5 April 2016 | By Victoria White
RedHill has announced encouraging top-line interim results from its CEASE-MS study of RHB-104 in patients with relapsing-remitting multiple sclerosis...
World’s first public dengue immunisation programme starts
5 April 2016 | By Victoria White
Dengvaxia vaccinations of one million students from 6,000 public schools in the Philippines are to begin this year...
Saxenda demonstrates significant improvements in cardiometabolic risk factors
5 April 2016 | By Victoria White
In a three year trial, individuals treated with Saxenda lost more weight (6.1%) than those treated with placebo (1.9%)...
CHMP adopts positive opinion for eribulin in advanced liposarcoma
5 April 2016 | By Victoria White
The European Medicines Agency’s CHMP has adopted a positive opinion for a licence extension for Eisai’s Halaven (eribulin)...
